BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
2
SALT AND CRYSTAL FORM OF EGFR INHIBITOR, AND COMPOSITION AND USE THEREOFBDB
Betta Pharmaceuticals
17
NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCERBDB
Korea Research Institute of Chemical Technology
27
ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOFBDB
Chengdu Di''Ao Jiuhong Pharmaceutical Factory
21
Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorBDB
Chia Tai Tianqing Pharmaceutical Group
219
SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORSBDB
Boehringer Ingelheim International
43
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerBDB
Korea Research Institute of Chemical Technology
3
Pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing sameBDB
Oncobix